Prenatal exposure of bupropion may enhance agitation, anxiety responses, and sensitivity to cocaine effects in adult mice

Chinese Journal of Physiology

Volumn 50, Issue 1, 2007, Pages 1-8

  Su, Shu Wen ^a   Cherng, Chian Fang G ^b   Lin, Yin Chiu ^a   Yu, Lung ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b DEPARTMENT OF ELECTRONIC ENGINEERING   (Taiwan)

Author keywords

Cocaine; Excitability; Mice; Prenatal; Reward; Sensitization; Sex; Stress

Indexed keywords

AMFEBUTAMONE; COCAINE; ANTIDEPRESSANT AGENT;

AGITATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; BODY WEIGHT; C57BL 6 MOUSE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENTIATION; DRUG SENSITIVITY; FEMALE; LOCOMOTION; MOBILIZATION; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; NORADRENERGIC SYSTEM; OPEN FIELD TEST; PRENATAL EXPOSURE; PRENATAL STRESS; SENSITIZATION; SEXUAL BEHAVIOR; SMOKING; THIRD TRIMESTER PREGNANCY; AGING; ANIMAL; DRUG EFFECT; MOTOR ACTIVITY; PATHOPHYSIOLOGY; PREGNANCY; PSYCHOLOGICAL ASPECT; RESTLESSNESS; REWARD;

AGING; ANIMALS; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANXIETY; BUPROPION; COCAINE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MICE; MOTOR ACTIVITY; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PSYCHOMOTOR AGITATION; REWARD;

EID: 34447645117     PISSN: 03044920     EISSN: 26660059     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Ansorge, M.S., Zhou, M., Lira, A., Hen, R. and Gingrich, J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306: 879-881, 2004.
2. Ascher, J.A., Cole, J.O., Colin, J.N., Feighner, J.P., Ferris, R.M., Fibiger, H.C., Golden, R.N., Martin, P., Potter, W.Z. and Richelson, E. Bupropion: a review of its mechanism of antidepressant activity. J. Clin. Psychiatry 56: 395-401, 1995.
3. Borsini, F., Podhorna, J. and Marazziti, D. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163: 121-141, 2002.
4. Carrasco, M.C., Vicens, P., Vidal, J. and Redolat, R. Effects of acute administration of bupropion on behavior in the elevated plus-maze test by NMRI mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 28: 1135-1141, 2004.
5. Chen, H.H., Yang, Y.K., Yeh, T.L., Cherng, C.F., Hsu, H.C., Hsiao, S.Y. and Yu, L. Methamphetamine-induced conditioned place preference is facilitated by estradiol pretreatment in female mice. Chinese J. Physiol. 46: 169-174, 2003.
6. Cohen, L.S. and Rosenbaum, J.F. Psychotropic drug use during pregnancy: weighing the risks. J. Clin. Psychiatry 59 (Suppl 2): 18-28, 1998.
7. Cooper, B.R., Hester, T.J. and Maxwell, R.A. Behavioral and biochemical effects of the antidepressant bupropion (Wellbutrin): evidence for selective blockade of dopamine uptake in vivo. J. Pharmacol. Exp. Ther. 215: 127-134, 1980.
8. Crone, C.C. and Gabriel, G.M. Treatment of anxiety and depression in transplant patients: pharmacokinetic considerations. Clin. Pharmacokinet. 43: 361-394, 2004.
9. Dong, J. and Blier, P. Modification of norepinephrine and serotonin, but not dopamine, neuron firing by sustained bupropion treatment. Psychopharmacology (Berl) 155: 52-57, 2001.
10. Feighner, J.P. Mechanism of action of antidepressant medications. J. Clin. Psychiatry 60 (suppl 4): 4-11, 1999.
11. Hendrick, V., Stowe, Z.N., Altshuler, L.L., Hwang, S., Lee, E. and Haynes, D. Placental passage of antidepressant medications. Am. J. Psychiatry 160: 993-996, 2003.
12. Hsiao, S.Y., Cherng, C.G., Yang, Y.K., Yeh, T.L. and Yu, L. Prenatal bupropion exposure enhances the cocaine reward and stress susceptibility in adult mice. Chinese J. Physiol. 48: 1-7, 2005.
13. Hughes, J.R., Stead, L.F. and Lancaster, T. Antidepressants for smoking cessation. Cochrane Database Syst. Rev. 2: CD000031, 2003.
14. Jackson, L.R., Robinson, T.E. and Becker, J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology31: 129-138, 2006.
15. Joshi, D., Naidu, P.S., Singh, A. and Kulkami, S.K. Reversal of triazolam tolerance and withdrawal-induced hyperlocomotor activity and anxiety by bupropion in mice. Pharmacology75: 93-97, 2005.
16. Kalivas, P.W., Pierce, R.C., Cornish, J. and Sorg, B.A. A role for sensitization in craving and relapse in cocaine addiction. J. Psychopharmacol. 12: 49-53, 1998.
17. Kulin, N.A., Pastuszak, A., Sage, S.R., Schick-Boschetto, B., Spivey, G., Feldkamp, M., Ormond, K., Matsui, D., Stein-Schechman, A.K., Cook, L., Brochu, J., Rieder, M. and Koren, G.. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective control multicenter study. J. Am. Med. Assoc. 279: 609-610, 1998.
18. Li, S.X., Perry, K.W. and Wong, D.T. Influence of fluoxetine on the ability of bupropion to modulate extracellular dopamine and norepinephrine concentrations in three mesocorticolimbic areas of rats. Neuropharmacology42: 181-190, 2002.
19. Lien, W.H., Yeh, T.L., Yang, Y.K., Cherng, C.G., Chen, H.H., Chen, P.S. and Yu, L. Cycloheximide enhances maintenance of methamphetamine-induced conditioned place preference. Chinese J. Physiol. 47: 23-30, 2004.
20. Marcus, S.M., Barry, K.L., Flynn, H.A., Tandon, R. and Greden, J. F. Treatment guidelines for depression in pregnancy. Ira. J. Gynaecol. Obstet. 72: 61-70, 2001.
21. Pellow, S. and File, S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 24: 525-529, 1986.
22. Pohland, R.C., Byrd, T.K., Hamilton, M. and Koons, J.R. Placental transfer and fetal distribution of fluoxetine in the rat. Toxicol. Appl. Pharmacol. 98: 198-205, 1989.
23. Preskorn, S.H. and Othmer, S.C. Evaluation of bupropion hydrochloride: the first of a new class of atypical antidepressants. Pharmacotherapy 4: 20-34, 1984.
24. Redolat, R., Gomez, M.C., Vicens, P. and Carrasco, M.C. Bupropion effects on aggressiveness and anxiety in OF1 male mice. Psychopharmacology (Berl) 177: 418-427, 2005.
25. Richmond, R. and Zwar, N. Review of bupropion for smoking cessation. Drug Alcohol Rev. 22: 203-220, 2003.
26. Rygula, R., Abumaria, N., Flugge, G., Fuchs, E., Ruther, E. and Havemann-Reinecke, U. Anhedonia and motivational deficits in rats: impact of chronic social stress. Behav. Brain Res. 162: 127-134, 2005.
27. Salin-Pascual, R.J., Alcocer-Castillejos, N.V. and Alejo-Galarza, G. Nicotine dependence and psychiatric disorders. Rev. Invest. Clin. 55: 677-693, 2003.
28. Sasaki-Adams, D.M. and Kelley, A.E. Serotonin-dopamine interactions in the control of conditioned reinforcement and motor behavior. Neuropsychopharmacology 25-440-452, 2003.
29. Simon, N.M., Emmanuel, N., Ballenger, J., Worthington, J.J., Kinrys, G., Korbly, N.B., Farach, F.J. and Pollack, M.H. Bupropion sustained release for panic disorder. Psychopharmacol. Bull. 37: 66-72, 2003.
30. Solhkhah, R., Wilens, T.E., Daly, J., Prince, J.B., Van Patten, S.L. and Biederman, J. Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders. J. Child Adolesc. Psychopharmacol. 15: 777-786, 2005.
31. Stahl, S.M. Selecting an antidepressant by using mechanism of action to enhance efficacy and avoid side effects. J. Clin. Psychiatry 59 (suppl 18): 23-29, 1998.
32. Tomarken, A.J., Dichter, G.S., Freid, C., Addington, S. and Shelton, R.C. Assessing the effects of bupropion SR on mood dimensions of depression. J. Affect Disord. 78: 235-241, 2004.
33. Van Gaalen, M.M. and Steckler, T. Behavioural analysis of four mouse strains in an anxiety test battery. Behav. Brain Res. 1 i 5: 95-106, 2000.
34. Zarrindast, M.R. and Hosseini-Nia, T. Anorectic and behavioural effects of bupropion. Gen. Pharmacol. 19: 201-204, 1988.
35. Zimmerman, M., Posternak, M.A., Atiullah, N., Friedman, M., Boland, R.J., Baymiller, S., Berlowitz, S.L., Rahman, S., Uy, K.K., Singer, S. and Chelminski, I. Why isn't bupropion the most frequently prescribed antidepressant? J. Clin. Psychiatry 66: 603-610, 2005.
36. Zocchi, A., Varnier, G., Arban, R., Griffante, C., Zanetti, L., Bettelini, L., Marchi, M., Gerrard, P.A. and Corsi, M. Effects of antidepressant drugs and GR 205171, an neurokinin-1 (NK1) receptor antagonist, on the response in the forced swim test and on monoamine extracellular levels in the frontal cortex of the mouse. Neurosci. Lett. 345: 73-76, 2003.